CAN
BNTC icon

Cetera Advisor Networks’s Benitec Biopharma BNTC Stock Holding History

Cetera Advisor Networks’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-727
Closed -$2.59K – 2617
2023
Q1 		$2.59K Sell
727
-251
-26% -$1.02K ﹤0.01% 2580
2022
Q4 		$2.83K Buy
+978
New +$3.31K ﹤0.01% 2532

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cetera Advisor Networks's BNTC Position: Q2 2023 in Review

Cetera Advisor Networks sold out of Benitec Biopharma (BNTC) in Q2 2023, closing a stake of 727 shares — an estimated $2.59K sold.

Cetera Advisor Networks first reported a position in BNTC in Q4 2022 and held it in 2 quarters. The position peaked at $2.83K in Q4 2022. 17 funds tracked by Wall St. Rank hold BNTC as of Q2 2023.

  • Cetera Advisor Networks reported no remaining Benitec Biopharma position as of Q2 2023 after selling out during the quarter.
  • Cetera Advisor Networks sold 727 Benitec Biopharma shares in Q2 2023, an estimated $2.59K.
  • Cetera Advisor Networks first reported a position in Benitec Biopharma in Q4 2022 and held it in 2 quarters.
  • Cetera Advisor Networks's Benitec Biopharma position peaked at $2.83K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2023.

Based on Cetera Advisor Networks's 13F filing for Q2 2023, filed 10 Aug 2023.